We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


NovaBone Putty® MIS Delivery System Approved by FDA for Orthopedic Surgery

Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "NovaBone Putty® MIS Delivery System Approved by FDA for Orthopedic Surgery"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

NovaBone Products, a medical device company, has announced the U.S. Food and Drug Administration’s (FDA) approval of the NovaBone Putty® MIS Delivery System designed for use in minimally invasive orthopedic procedures.

The new system is characteristic of NovaBone Product’s ability to develop medical device technology designed for the needs of orthopedic surgeons. The NovaBone MIS Delivery System improves conventional delivery methods of bone graft substitutes through a syringe pre-loaded with NovaBone Putty and 6mm diameter cannulas at varying lengths. The system was developed for surgeons who require controlled and precise delivery of bone grafting material to the surgical site.

The NovaBone Putty MIS Delivery System delivers an osteoconductive matrix while signaling and stimulating osteoblastic activity to the orthopedic surgical site.

The product is approved for use in orthopedic surgeries of the extremities, the pelvis and posterolateral spine.

“The launch of the MIS Delivery System will be just the beginning of products our company will be offering to spine surgeon, neurosurgeons and orthopedic surgeons,” said Art Wotiz, President of NovaBone Products. “As a growing medical device company, we will introduce a number of new products this year and through 2011 that are based on advancements in bioengineered medical technology.”

The products will represent patented medical technology that will keep NovaBone Products in the forefront of the marketplace with orthopedic bone graft options.